Cargando…
Endothelial dysfunction in COVID-19: Current findings and therapeutic implications
Coronavirus disease 2019 (COVID-19) increases the risk of several non-pulmonary complications such as acute myocardial injury, renal failure or thromboembolic events. A possible unifying explanation for these phenomena may be the presence of profound endothelial dysfunction and injury. This review p...
Autores principales: | Nägele, Matthias P., Haubner, Bernhard, Tanner, Felix C., Ruschitzka, Frank, Flammer, Andreas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554490/ https://www.ncbi.nlm.nih.gov/pubmed/33161318 http://dx.doi.org/10.1016/j.atherosclerosis.2020.10.014 |
Ejemplares similares
-
Eyes on amyloidosis: microvascular retinal dysfunction in cardiac amyloidosis
por: Zampiccoli, Emanuel, et al.
Publicado: (2022) -
Endothelial cell infection and endotheliitis in COVID-19
por: Varga, Zsuzsanna, et al.
Publicado: (2020) -
Trends in voice characteristics in patients with heart failure (VENTURE) in Switzerland: Protocol for a longitudinal observational pilot study
por: Wu, Fan, et al.
Publicado: (2023) -
Cocoa, Blood Pressure, and Vascular Function
por: Ludovici, Valeria, et al.
Publicado: (2017) -
Endocrine hormone imbalance in heart failure with reduced ejection fraction: A cross‐sectional study
por: Nägele, Matthias P., et al.
Publicado: (2022)